Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Pritchard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Orthopaedics and Related Research|April 16, 2002
Etiology of osteosarcomaBruno Fuchs, Douglas J Pritchard
Journal of Spinal Disorders & Techniques|July 20, 2002
Vertebra plana caused by primary Ewing sarcoma: case report and review of the literaturePanayiotis J Papagelopoulos, Bradford L Currier, Evanthia Galanis, et al.
The Journal of Bone and Joint Surgery. American Volume|May 1, 2004
Long-term results of segmental prosthesis fixation by extracortical bone-bridging and ingrowthEdmund Y S Chao, Bruno Fuchs, Charles M Rowland, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Orthopaedics and Related Research|April 16, 2002
Etiology of osteosarcomaBruno Fuchs, Douglas J Pritchard
Journal of Spinal Disorders & Techniques|July 20, 2002
Vertebra plana caused by primary Ewing sarcoma: case report and review of the literaturePanayiotis J Papagelopoulos, Bradford L Currier, Evanthia Galanis, et al.
The Journal of Bone and Joint Surgery. American Volume|May 1, 2004
Long-term results of segmental prosthesis fixation by extracortical bone-bridging and ingrowthEdmund Y S Chao, Bruno Fuchs, Charles M Rowland, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
The New England Journal of Medicine|February 21, 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of boneHolcombe E Grier, Mark D Krailo, Nancy J Tarbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group studyJames S Miser, Mark D Krailo, Nancy J Tarbell, et al.
Pediatric Blood & Cancer|June 23, 2007
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology GroupJames S Miser, Robert E Goldsby, Zhengjia Chen, et al.
Pageof 1